Please use this identifier to cite or link to this item:
doi:10.22028/D291-43315
Title: | Rapid analysis of amatoxins in human urine by means of affinity column chromatography and liquid chromatography-high-resolution tandem mass spectrometry |
Author(s): | Vollmer, Aline C. Fecher-Trost, Claudia Bever, Candace S. Tam, Christina C. Wagmann, Lea Meyer, Markus R. |
Language: | English |
Title: | Scientific Reports |
Volume: | 14 |
Issue: | 1 |
Publisher/Platform: | Springer Nature |
Year of Publication: | 2024 |
Free key words: | Method development Amatoxins Monoclonal antibody Magnetic beads Afnity column chromatography Liquid chromatography-high-resolution mass spectrometry |
DDC notations: | 610 Medicine and health |
Publikation type: | Journal Article |
Abstract: | Analysis of amatoxins is of great importance as these cyclic peptides contribute to a high number of fatalities each year. Development of analytical approaches needs to focus on rapid, sensitive, and reliable methods. By establishing an afnity column chromatography-based assay using the monoclonal amanitin antibody AMA9G3 and liquid chromatography (LC) coupled to high-resolution mass spectrometry (HRMS) for the trace detection of α-, β-, and γ-amanitin in human urine samples to confrm ingestion, we report the frst approach that extents the current status of amatoxin analysis. The presented procedure allows detection of amatoxins in human urine down to 1 ng/mL. The method was successfully validated qualitatively for α- and γ-amanitin according to international recommendations. A proof of concept was performed by analyzing 37 urine samples after suspected amatoxin consumption submitted for regular clinical toxicological analysis. Using this antibody-based enrichment strategy, acute amatoxin intoxications can be determined within 90 min and due to the high sensitivity and selectivity, a comparable approach using target specifc antibodies may also be used for other toxicological relevant peptides. |
DOI of the first publication: | 10.1038/s41598-024-72463-3 |
URL of the first publication: | https://www.nature.com/articles/s41598-024-72463-3 |
Link to this record: | urn:nbn:de:bsz:291--ds-433152 hdl:20.500.11880/38838 http://dx.doi.org/10.22028/D291-43315 |
ISSN: | 2045-2322 |
Date of registration: | 29-Oct-2024 |
Description of the related object: | Supplementary Information |
Related object: | https://static-content.springer.com/esm/art%3A10.1038%2Fs41598-024-72463-3/MediaObjects/41598_2024_72463_MOESM1_ESM.pdf |
Faculty: | M - Medizinische Fakultät |
Department: | M - Experimentelle und Klinische Pharmakologie und Toxikologie |
Professorship: | M - Prof. Dr. Veit Flockerzi M - Prof. Dr. Markus Meyer |
Collections: | SciDok - Der Wissenschaftsserver der Universität des Saarlandes |
Files for this record:
File | Description | Size | Format | |
---|---|---|---|---|
s41598-024-72463-3.pdf | 1,02 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License